(Q38010650)

26 August 2017

title

Gastroesophageal reflux disease and sleep disturbances (English)

1 reference

gastroesophageal reflux disease

26 August 2017

main subject

0 references

1

Yasuhiro Fujiwara

1 reference

26 August 2017

Tetsuo Arakawa

2

1 reference

26 August 2017

Ronnie Fass

series ordinal

3

1 reference

26 August 2017

publication date

17 May 2012

1 reference

Journal of Gastroenterology

26 August 2017

published in

1 reference

26 August 2017

volume

47

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

760-769

1 reference

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Epidemiology and clinical characteristics of GERD in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Association of gastroesophageal reflux disease with weight gain and apnea, and their disturbance on sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Predictors of heartburn during sleep in a large prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Effects of gastroesophageal reflux disease on sleep and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Review article: sleep-related gastro-oesophageal reflux as a distinct clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Esophageal acid clearance during sleep in patients with Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Circadian Dynamics of Gastric Acid Secretion and Pharmacodynamics of H2 Receptor Blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Proton pump inhibitor failure--what are the therapeutic options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Effect of sleep on gastroesophageal physiology and airway protective mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Gastrointestinal functioning during sleep: a new horizon in sleep medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Conscious awakenings are commonly associated with Acid reflux events in patients with gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Increased oesophageal acid exposure at the beginning of the recumbent period is primarily a recumbent‐awake phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Reassessment of the principal characteristics of gastroesophageal reflux during the recumbent period using integrated actigraphy-acquired information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Riser's reflux--an eye-opening experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Association between dinner-to-bed time and gastro-esophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Effect of gastroesophageal reflux disease on sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Comparison of morning and evening administration of rabeprazole for gastro‐oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double‐blind, cross‐over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Review of immediate-release omeprazole for the treatment of gastric acid-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Dexlansoprazole MR for the management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Surgical trial investigating nocturnal gastroesophageal reflux and sleep (STINGERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Effect of zolpidem on the sleep arousal response to nocturnal esophageal acid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

Occurrence of nighttime gastroesophageal reflux in disturbed and normal sleepers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0601-4

THE FREQUENCY OF DEGLUTITION IN MAN

21 January 2018

1 reference

12 December 2020

Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan

1 reference

12 December 2020

Effect of sleep, spontaneous gastroesophageal reflux, and a meal on upper esophageal sphincter pressure in normal human volunteers

1 reference

12 December 2020

Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis

1 reference

12 December 2020

Pathophysiology of gastroesophageal reflux: motility factors

1 reference

12 December 2020

Esophageal motility in Japanese patients with Barrett's esophagus.

1 reference

12 December 2020

Rate of flow of human parotid, sublingual, and submaxillary secretions during sleep

1 reference

12 December 2020

Helicobacter pylori infection influences nocturnal gastric acid breakthrough

1 reference

12 December 2020

Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole

1 reference

12 December 2020

Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily

1 reference

12 December 2020

Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.

1 reference

12 December 2020

Gastric acid secretion and sleep stages during natural night sleep

1 reference

12 December 2020

Circadian variation in gastric emptying of meals in humans

1 reference

12 December 2020

Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study

1 reference

12 December 2020

Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study.

1 reference

12 December 2020

10.1007/S00535-012-0601-4

Identifiers

DOI

1 reference

26 August 2017

1 reference